Characterization of immunogenic Neu5Gc in bioprosthetic heart valves

被引:58
作者
Reuven, Eliran Moshe [1 ]
Ben-Arye, Shani Leviatan [1 ]
Marshanski, Tal [1 ]
Breimer, Michael E. [2 ]
Yu, Hai [3 ]
Fellah-Hebia, Imen [4 ]
Roussel, Jean-Christian [4 ]
Costa, Cristina [5 ]
Galinanes, Manuel [6 ,7 ]
Manez, Rafael [5 ]
Le Tourneau, Thierry [8 ]
Soulillou, Jean-Paul [9 ]
Cozzi, Emanuele [10 ]
Chen, Xi [3 ]
Padler-Karavani, Vered [1 ]
机构
[1] Tel Aviv Univ, Dept Cell Res & Immunol, Tel Aviv, Israel
[2] Univ Gothenburg, Inst Clin Sci, Dept Surg, Sahlgrenska Acad, Gothenburg, Sweden
[3] Univ Calif Davis, Dept Chem, Davis, CA 95616 USA
[4] Univ Hosp, Dept Thorac & Cardiovasc Surg, Inst Thorax, Nantes, France
[5] Bellvitge Biomed Res Inst IDIBELL, Infect Dis & Transplantat Div, Barcelona, Spain
[6] Hosp Univ Vall dHebron, Dept Cardiac Surg, Reparat Therapy Heart, Barcelona, Spain
[7] Vall dHebron Res Inst, Barcelona, Spain
[8] Univ Hosp, Inst Thorax, Dept Cardiol, Nantes, France
[9] Ctr Hosp Univ Nantes, Inst Transplantat Urol Nephrol, INSERM, Unite Mixte Rech 1064, Nantes, France
[10] Padua Univ Hosp, Transplant Immunol Unit, Dept Transfus Med, Padua, Italy
基金
美国国家卫生研究院;
关键词
immunology; Neu5Gc; transplantation; valvular heart disease; xeno-antigens; N-GLYCOLYLNEURAMINIC ACID; NON-GAL ANTIBODIES; SIALIC-ACID; ALPHA-GAL; ANTI-NEU5GC ANTIBODIES; NATIONAL DATABASE; KO ERA; REPLACEMENT; XENOTRANSPLANTATION; ANTIGENS;
D O I
10.1111/xen.12260
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
Background: The two common sialic acids (Sias) in mammals are N-acetylneuraminic acid (Neu5Ac) and its hydroxylated form N-glycolylneuraminic acid (Neu5Gc). Unlike most mammals, humans cannot synthesize Neu5Gc that is considered foreign and recognized by circulating antibodies. Thus, Neu5Gc is a potential xenogenic carbohydrate antigen in bioprosthetic heart valves (BHV) that tend to deteriorate in time within human patients. Methods: We investigated Neu5Gc expression in non-engineered animal-derived cardiac tissues and in clinically used commercial BHV, and evaluated Neu5Gc immunogenicity on BHV through recognition by human anti-Neu5Gc IgG. Results: Neu5Gc was detected by immunohistochemistry in porcine aortic valves and in porcine and bovine pericardium. Qualitative analysis of Sia linkages revealed Siaa2-3> Siaa2-6 on porcine/bovine pericardium while the opposite in porcine aortic/pulmonary valve cusps. Similarly, six commercial BHV containing either porcine aortic valve or porcine/bovine/equine pericardium revealed Siaa2-3> Siaa2-6 expression. Quantitative analysis of Sia by HPLC showed porcine/bovine pericardium express 4-fold higher Neu5Gc levels compared to the porcine aortic/pulmonary valves, with Neu5Ac at 6-fold over Neu5Gc. Likewise, Neu5Gc was expressed on commercial BHV (186.3 +/- 16.9 pmol Sia/mu g protein), with Neu5Ac at 8-fold over Neu5Gc. Affinity-purified human anti-Neu5Gc IgG showing high specificity toward Neu5Gc-glycans (with no binding to Neu5Ac-glycans) on a glycan microarray, strongly bound to all tested commercial BHV, demonstrating Neu5Gc immune recognition in cardiac xenografts. Conclusions: We conclusively demonstrated Neu5Gc expression in native cardiac tissues, as well as in six commercial BHV. These Neu5Gc xeno-antigens were recognized by human anti-Neu5Gc IgG, supporting their immunogenicity. Altogether, these findings suggest BHV-Neu5Gc/anti-Neu5Gc may play a role in valve deterioration warranting further investigation.
引用
收藏
页码:381 / 392
页数:12
相关论文
共 50 条
  • [1] Glycans in immune recognition and response
    Amon, Ron
    Reuven, Eliran Moshe
    Ben-Arye, Shani Leviatan
    Padler-Karavani, Vered
    [J]. CARBOHYDRATE RESEARCH, 2014, 389 : 115 - 122
  • [2] Characterization of acid and non-acid glycosphingolipids of porcine heart valve cusps as potential immune targets in biological heart valve grafts
    Barone, Angela
    Benktander, John
    Teneberg, Susann
    Breimer, Michael E.
    [J]. XENOTRANSPLANTATION, 2014, 21 (06) : 510 - 522
  • [3] Gal/non-Gal antigens in pig tissues and human non-Gal antibodies in the GalT-KO era
    Breimer, Michael E.
    [J]. XENOTRANSPLANTATION, 2011, 18 (04) : 215 - 228
  • [4] Isolated aortic valve replacement in North America comprising 108,687 patients in 10 years: Changes in risks, valve types, and outcomes in the Society of Thoracic Surgeons National Database
    Brown, James M.
    O'Brien, Sean M.
    Wu, Changfu
    Sikora, Jo Ann H.
    Griffith, Bartley P.
    Gammie, James S.
    [J]. JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY, 2009, 137 (01) : 82 - 90
  • [5] Byrne GW, 2014, XENOTRANSPLANTATION, V21, P11, DOI 10.1111/xen.12072
  • [6] Identification of New Carbohydrate and Membrane Protein Antigens in Cardiac Xenotransplantation
    Byrne, Guerard W.
    Stalboerger, Paul G.
    Du, Zeji
    Davis, Tessa R.
    McGregor, Christopher G. A.
    [J]. TRANSPLANTATION, 2011, 91 (03) : 287 - 292
  • [7] Chikwe J, 2015, JAMA-J AM MED ASSOC, V313, P1435, DOI 10.1001/jama.2015.3164
  • [8] Christiansen Dale, 2012, Methods Mol Biol, V885, P47, DOI 10.1007/978-1-61779-845-0_4
  • [9] Valvular heart disease: the next cardiac epidemic
    d'Arcy, J. L.
    Prendergast, B. D.
    Chambers, J. B.
    Ray, S. G.
    Bridgewater, B.
    [J]. HEART, 2011, 97 (02) : 91 - 93
  • [10] Aortic valve replacement with Toronto SPV bioprosthesis: Optimal patient survival but suboptimal valve durability
    David, Tirone E.
    Feindel, Christopher M.
    Bos, Joanne
    Ivanov, Joan
    Armstrong, Susan
    [J]. JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY, 2008, 135 (01) : 19 - 24